Rossari Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,202.91

975.17

1,072.84

690.41

600.09

Operating profit

161.25

122.65

122.79

120.86

105.01

Interest

9.70

4.62

2.55

2.99

3.68

Gross profit

158.32

121.63

132.95

128.07

104.96

EPS (Rs)

18.04

12.94

14.44

15.23

12.91

Other income

6.77

3.60

12.70

10.21

3.63

Stock adjustment

-13.58

-12.97

-10.34

-7.22

2.44

Raw material

625.73

553.96

707.98

452.13

369.26

Power and fuel

-

-

-

-

-

Employee expenses

51.46

57.35

43.53

36.66

37.13

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

378.04

254.19

208.88

87.99

86.25

Provisions made

-

-

-

-

-

Depreciation

24.19

25.98

26.27

22.07

16.85

Taxation

34.49

24.26

27.21

26.90

22.59

Net profit / loss

99.65

71.39

79.47

79.10

65.52

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

11.05

11.03

11.01

10.39

10.15

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.41

12.58

11.45

17.50

17.50

GPM (%)

13.09

12.43

12.25

18.28

17.39

NPM (%)

8.24

7.29

7.32

11.29

10.85